Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis
Tofacitinib and upadacitinib appear to have similar effectiveness and safety profiles when used for the treatment of ASUC.
Authors
- Joëlle St‐Pierre (ORCID: https://orcid.org/0000-0002-7393-4950)
- Stéphane Nancey (ORCID: https://orcid.org/0000-0003-2088-1442)
- David Laharie (ORCID: https://orcid.org/0000-0002-4753-6676)
- Michael Colwill (ORCID: https://orcid.org/0000-0001-6925-8358)
- Daniel Bergemalm (ORCID: https://orcid.org/0000-0002-1906-0746)
- Jonas Halfvarson (ORCID: https://orcid.org/0000-0003-0122-7234)
- Sailish Honap (ORCID: https://orcid.org/0000-0001-6657-2763)
- Byong Duk Ye (ORCID: https://orcid.org/0000-0001-6647-6325)
- Paulo Gustavo Kotze (ORCID: https://orcid.org/0000-0002-9632-6691)
- Ferdinando D’Amico (ORCID: https://orcid.org/0000-0002-8591-6995)
- Sophie Vieujean (ORCID: https://orcid.org/0000-0002-1859-7146)
- Taku Kobayashi (ORCID: https://orcid.org/0000-0002-2073-4234)
- Bénédicte Caron
- Ahmad Albshesh (ORCID: https://orcid.org/0000-0001-8962-4263)
- Mathurin Fuméry (ORCID: https://orcid.org/0000-0002-2337-2902)
- Anthony Buisson (ORCID: https://orcid.org/0000-0002-6347-409X)
- Lucas Guillo (ORCID: https://orcid.org/0000-0001-9024-8541)
- Konstantinos Κarmiris (ORCID: https://orcid.org/0000-0003-3552-3074)
- Kamal Patel (ORCID: https://orcid.org/0000-0002-8114-2283)
- Romain Altwegg (ORCID: https://orcid.org/0000-0003-4618-7942)
- Akira Nogami (ORCID: https://orcid.org/0009-0003-0706-0436)
- Éric Vicaut (ORCID: https://orcid.org/0000-0001-6303-8557)
- Maria Nachury (ORCID: https://orcid.org/0000-0001-9583-8946)
- Catherine Le Berre (ORCID: https://orcid.org/0000-0002-1124-2019)
- Mathieu Uzzan
- Xavier Roblin
- Xavier Hébuterne
- Milan Lukáš
- Laurent Peyrin-Biroulet
- David Rubin
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Ulsan College (KR)
- Toho University (JP)
- Université de Bordeaux (FR)
- Vita-Salute San Raffaele University (IT)
- Inserm (FR)
- University of Calgary (CA)
- Pontifícia Universidade Católica do Paraná (BR)
- Aix-Marseille Université (FR)
- Université de Lille (FR)
- Örebro University (SE)
- Sheba Medical Center (IL)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Asan Medical Center (KR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- University of Chicago (US)
- University of Ulsan (KR)
- Toho University Omori Medical Center (JP)
- Hospices Civils de Lyon (FR)
- University of Clermont Auvergne (FR)
- Hôpital Fernand-Widal (FR)
- Iscare I.V.F (CZ)
- Hôpital Lariboisière (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Centre d'Investigation Clinique de Nantes (FR)
- Lille Inflammation Research International Center (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- The General Hospital of Heraklion "Venizeleio-Pananio" (GR)
- Hôpital Saint Eloi (FR)
- Kitasato Institute Hospital (JP)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
- Périnatalité & Risques Toxiques (FR)
- Institute for Translational Research in Inflammation (FR)
- Nutrition-Génétique et Exposition aux Risques Environnementaux (FR)
- Université de Picardie Jules Verne (FR)
- Kitasato University (JP)
- Université de Lorraine (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Clinical Gastroenterology and Hepatology
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1016/j.cgh.2025.07.025
- Citations
- 5
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 9.09